BLUEWHALE
Live / Allowed — Notice of allowance issued (as of 02 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Oct 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98212459
- Mark type
- Stylized text
- Filed
- 06 Oct 2023
- Published for opposition
- 08 Jul 2025
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Reagents for medical use; vaccines
- Class 040 — Treatment of materials: Custom manufacturing services in the field of pharmaceuticals for cell and gene therapy; Biomanufacturing for others, namely, manufacturing of pharmaceuticals for cell and gene therapy using biological organisms in the manufacturing process
- Class 042 — Scientific and technological services: Scientific and medical research and vaccine development services in the field of cell and gene therapy
Owner
- BlueWhale Bio, Inc., Philadelphia, PA, US
- BlueWhale Bio, Inc., Philadelphia, PA, US
Prosecution history
- 12 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Feb 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 24 Feb 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 03 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Dec 2024 — NON-FINAL ACTION E-MAILED
- 03 Dec 2024 — NON-FINAL ACTION WRITTEN
- 25 Nov 2024 — PREVIOUS ALLOWANCE COUNT WITHDRAWN